Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.05.02.490365

Modeling the kinetics of amyloid beta pores and long-term evolution of their Ca2+ toxicity

Abstract

The formation of cation-permeable pores due to amyloid beta (A{beta}) in the plasma membrane (PM) and membranes of intracellular organelles has been shown to cause disruption of Ca2+ homeostasis in Alzheimers disease, leading to neuronal malfunction and degeneration. However, detailed information about the formation, function, and time-evolution of A{beta} pores are still lacking. Here we present a comprehensive analysis to show that the Ca2+ toxicity of PM pores formed by A{beta}42 progressively increases over the duration of the experiments that last for more than an hour. This mainly results from a progressively increasing number of pores and activity of individual pores having higher open probability (Po) and Ca2+ conductance. To gain deeper insight into the function and evolution of A{beta}42 pores and establish their role in Ca2+ toxicity beyond experimental times scales, we developed a data-driven computational model that not only mimics the kinetics of these pores at a given time but also tracks their time-evolution over many hours. Our model suggests that the rising toxicity of A{beta}42 pores over time is a combined result of the large number of short-lived pores with low Ca2+ conductance and long-lived higher-conductance pores but fewer in number. Analysis and modeling of the voltage-dependent data show that A{beta}42 pores are most active when the cells membrane potential is near resting values, making the cell at rest especially more prone to Ca2+ disruptions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Shah, S. I., Demuro, A., Ullah, G.. 2022-05-03. Modeling the kinetics of amyloid beta pores and long-term evolution of their Ca2+ toxicity. https://doi.org/10.1101/2022.05.02.490365

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Nucleosome Core Allostery Governs Chromatin Recognition and Cell Fate

Nucleosomes regulate chromatin folding, accessibility, and factor recruitment. Current models primarily attribute these functions to histone tail modifications, while the core is largely viewed as a structural scaffold. Yet subtle changes within the nucleosome core can produce profound functional consequences, and the mechanisms underlying these effects remain unclear. Here, we describe nucleosome core allostery as a fundamental principle of chromatin regulation that amplifies the impact of minimal nucleosome variations. Leveraging natural differences between H2A.Z variants, we show that the nucleosome core encodes distinct conformational dynamics that propagate allosterically, thereby controlling nucleosome accessibility and recognition by chromatin factors. As a result, a single buried amino acid substitution alone is sufficient to reprogram nucleosome dynamics and bias cell identity. Our findings establish the nucleosome core as an allosteric regulatory module and provide a generalizable framework for how subtle variation within nucleosomes is amplified into diverse biological outcomes in development and disease.

cell biology↗

SOX4 Reprograms Adipose Stromal Cells into a Cancer-Associated Fibroblast-like State to Drive Metabolic Disease

Pathogenic adipose tissue remodeling promotes metabolic disease in obesity, but the mechanisms that establish this unhealthy tissue state remain poorly understood. Here, we show that obesity drives SOX4-dependent reprogramming of mesenchymal stromal cells (MSCs) into cancer-associated fibroblast-like (CAF-like) cells that promote adipose tissue dysfunction. TGF{beta} signaling is elevated in obesity and activates SOX4 in mouse and human MSCs, inducing their conversion to a CAF-like state. In mice, MSC-specific SOX4 activation induces the CAF-like program and exacerbates adipose tissue inflammation and glucose intolerance, whereas Sox4 deletion attenuates inflammation and improves glucose homeostasis during obesity. We further identify the growth factor Midkine (MDK) as a SOX4-regulated paracrine effector produced by CAF-like cells. MDK inhibition in obese mice reduces adipose tissue inflammation and improves metabolic function. Together, these findings define a TGF{beta}-SOX4-MDK stromal signaling axis that drives pathological adipose tissue remodeling in obesity and highlight this pathway as a potential therapeutic target for improving metabolic health.

cell biology↗

PDLIM5 Modulates YAP1 Localisation and Fibrogenic Gene Expression in Hepatic Stellate Cells

Hepatic stellate cells (HSCs) are the key cellular drivers of liver fibrosis. During liver injury and chronic inflammation HSCs adopt an activated phenotype and secrete fibrotic extracellular matrix (ECM) components such as collagen 1. Mechanical cues derived from the fibrotic ECM drive and support the activation of HSCs, via mechanisms that involve integrins and the mechano-sensitive transcriptional regulator YAP1. It is not yet well understood how external mechanical cues are translated into a molecular response that alters YAP1 nuclear shuttling. There is evidence that suggests the PDZ and LIM domain protein (PDLIM) 5 can regulate YAP1 shuttling in human epithelial cells. We therefore investigated whether PDLIM5 is expressed in HSCs and contributes to YAP1 associated HSC mechano-activation. PDLIM5 protein was detected in HSCs in fibrotic human and mouse liver. PDLIM5 transcript and protein were expressed by primary human and mouse HSCs and by the immortalised HSC LX-2 cell line. PDLIM5 localised with actin stress fibres suggesting a role in HSC adhesion. Co-immunoprecipitation and proximity ligation in LX-2 cells support an association between PDLIM5 and YAP1. We used pharmacological (paclitaxel) and genetic (siRNA and CRISPRi) approaches to inhibit PDLIM5 in HSCs. Inhibiting PDLIM5 reduced YAP1 nuclear localisation and fibrotic gene (COL1A1, ACTA2) expression in LX-2 cells. Overall, these data support a role for PDLIM5 in regulating YAP1 localisation and fibrogenic gene expression in HSCs.

cell biology↗